According to the latest data from CMS, 78 hospitals have attested to meaningful use stage 2 as of August 1.
“This recognition is another major milestone in the history of our EMR project and reflects the hard work of many people throughout Fletcher Allen,” said John Brumsted, MD, president and CEO of Fletcher Allen Health Care and Fletcher Allen Partners. “It speaks well to the quality of our system and the effort made by both providers and technical staff alike that we are among the very few medical centers to achieve this recognition.”
More articles on meaningful use stage 2:
Survey: Patients largely unaware of patient portal options
Study: Only 5.8% of hospitals could meet all MU2 requirements
Which stage 2 objectives are proving easiest, hardest to attest to
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
